Bachem Holding AG/€BANB
1D1W1MYTD1Y5YMAX
About Bachem Holding AG
Bachem Holding AG is a Swiss-based company specializing in the development and manufacturing of peptides and oligonucleotides, primarily serving the pharmaceutical and biotechnology industries. With its expertise in this niche area, Bachem offers products including active pharmaceutical ingredients (APIs) and research chemicals. Founded in 1971, the company has positioned itself as a key supplier for both commercial and clinical-stage clients. Bachem has production sites in Switzerland, Germany, the United Kingdom, and the United States, allowing for a robust global presence. The company's strategic positioning benefits from its focus on high-quality, innovative manufacturing processes that comply with stringent regulatory standards.
- Ticker
- €BANB
- Sector
- Health
- Primary listing
- XGAT
- Employees
- 2,725
- Headquarters
- Bubendorf, Switzerland
- Website
- www.bachem.com
BANB Metrics
BasicAdvanced
€6.2B
39.02
€2.12
-
€0.98
0.59%
Price and volume
Market cap
€6.2B
52-week high
€91.25
52-week low
€54.05
Average daily volume
122K
Dividend rate
€0.98
Financial strength
Current ratio
1.604
Quick ratio
0.456
Long term debt to equity
0.003
Total debt to equity
14.414
Dividend payout ratio (TTM)
45.30%
Interest coverage (TTM)
149.30%
Profitability
EBITDA (TTM)
224.992
Gross margin (TTM)
27.00%
Net profit margin (TTM)
21.02%
Operating margin (TTM)
21.81%
Effective tax rate (TTM)
5.05%
Revenue per employee (TTM)
€277,960
Management effectiveness
Return on assets (TTM)
4.54%
Return on equity (TTM)
10.63%
Valuation
Price to earnings (TTM)
39.016
Price to revenue (TTM)
8.203
Price to book
4.02
Price to tangible book (TTM)
4.11
Price to free cash flow (TTM)
-99.805
Free cash flow yield (TTM)
-1.00%
Free cash flow per share (TTM)
-0.829
Dividend yield (TTM)
1.19%
Forward dividend yield
0.59%
Growth
Revenue change (TTM)
4.51%
Earnings per share change (TTM)
10.44%
3-year revenue growth (CAGR)
9.70%
10-year revenue growth (CAGR)
12.28%
3-year earnings per share growth (CAGR)
14.51%
10-year earnings per share growth (CAGR)
13.98%
3-year dividend per share growth (CAGR)
6.27%
10-year dividend per share growth (CAGR)
7.18%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.